CBOA
AGN

Commonwealth Bank of Australia’s Allergan plc AGN Stock Holding History

Commonwealth Bank of Australia’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-62,495
Closed -$10.5M – 1113
2019
Q2 		$10.5M Buy
62,495
+13,125
+27% +$1.82M 0.1% 136
2019
Q1 		$7.22M Buy
49,370
+8,600
+21% +$1.25M 0.07% 179
2018
Q4 		$5.44M Buy
40,770
+17,132
+72% +$2.81M 0.06% 199
2018
Q3 		$4.5M Buy
23,638
+10,900
+86% +$2M 0.04% 241
2018
Q2 		$2.12M Buy
12,738
+12,484
+4,915% +$2M 0.02% 371
2018
Q1 		$41K Hold
254
– – ﹤0.01% 659
2017
Q4 		$39K Sell
254
-19
-7% -$3.41K ﹤0.01% 661
2017
Q3 		$53K Sell
273
-517
-65% -$120K ﹤0.01% 656
2017
Q2 		$190K Buy
790
+48
+6% +$11.3K ﹤0.01% 634
2017
Q1 		$177K Buy
742
+44
+6% +$10.2K ﹤0.01% 620
2016
Q4 		$147K Sell
698
-97
-12% -$20.1K ﹤0.01% 601
2016
Q3 		$183K Buy
795
+100
+14% +$24.4K ﹤0.01% 587
2016
Q2 		$160K Sell
695
-16
-2% -$3.69K ﹤0.01% 590
2016
Q1 		$190K Buy
711
+145
+26% +$41.5K ﹤0.01% 603
2015
Q4 		$176K Buy
566
+49
+9% +$14.6K ﹤0.01% 634
2015
Q3 		$140K Buy
517
+17
+3% +$5.22K ﹤0.01% 643
2015
Q2 		$152K Sell
500
-2,935
-85% -$875K ﹤0.01% 601
2015
Q1 		$1.02M Buy
3,435
+2,935
+587% +$837K 0.01% 447
2014
Q4 		$129K Sell
500
-6,300
-93% -$1.57M ﹤0.01% 580
2014
Q3 		$1.64M Buy
6,800
+2,600
+62% +$582K 0.02% 364
2014
Q2 		$937K Sell
4,200
-56,390
-93% -$11.7M 0.01% 469
2014
Q1 		$12.5M Sell
60,590
-1,915
-3% -$379K 0.08% 248
2013
Q4 		$10.5M Buy
+62,505
New +$9.77M 0.07% 267
2013
Q3 		– Sell
-11,220
Closed -$1.42M – 1315
2013
Q2 		$1.42M Buy
+11,220
New +$1.27M 0.01% 655

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Bank of Australia's AGN Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 62,495 shares — an estimated $10.5M sold.

Commonwealth Bank of Australia first reported a position in AGN in Q2 2013 and held it in 24 quarters. The position peaked at $12.5M in Q1 2014. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Commonwealth Bank of Australia reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 62,495 Allergan plc shares in Q3 2019, an estimated $10.5M.
  • Commonwealth Bank of Australia first reported a position in Allergan plc in Q2 2013 and held it in 24 quarters.
  • Commonwealth Bank of Australia's Allergan plc position peaked at $12.5M in Q1 2014.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.